VC firm blog
Everything we hold that BW Equities published.
Every article we hold from BW Equities.
Hydration Pharmaceuticals, which sells Hydralyte in North America, listed on the ASX, raising $17 million at 29 cents and closing 22.4% higher. Former Swisse executives hold key roles and large stakes.
Hydralyte's pre-float raise has closed with backing from the Gandel family and two small-cap funds, pricing the hydration business at $46.7 million ahead of its listing; BW Equities handled the raise.
Deals recorded from BW Equities's coverage. A round is listed once, however many of their articles mention it.
Companies named in BW Equities's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| Prestige Brands | 2 | |
| Swisse | 2 | |
| Amazon | Global e-commerce and technology company | 1 |
| Blackmores | Australian natural health company | 1 |
| BW Equities | 1 | |
| Gandel | 1 | |
| Hydralyte | 1 |
Investors named in BW Equities's articles, most-covered first.